SYNH — Syneos Health Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
- $4.46bn
- $7.08bn
- $5.39bn
Annual cashflow statement for Syneos Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 24.3 | 131 | 193 | 235 | 266 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 8.98 | 77.9 | 55.9 | 70.4 | 41.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.74 | -93.1 | -41.7 | -137 | -127 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 303 | 318 | 425 | 450 | 427 |
| Capital Expenditures | -54.6 | -64 | -50 | -56.8 | -93.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -90.9 | -17.7 | -454 | -284 | -12.2 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -145 | -81.7 | -504 | -340 | -106 |
| Financing Cash Flow Items | -29.5 | -15.9 | -57.4 | -39.7 | -37.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -319 | -215 | 178 | -278 | -339 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -166 | 7.76 | 108 | -166 | 5.53 |